These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10593171)

  • 1. Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies.
    Benjamin PA; Ling IT; Clottey G; Valero LM; Ogun SA; Fleck SL; Walliker D; Morgan WD; Birdsall B; Feeney J; Holder AA
    Mol Biochem Parasitol; 1999 Nov; 104(2):147-56. PubMed ID: 10593171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
    Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
    Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.
    Eslava I; Payares G; Pernia BM; Holder AA; Spencer LM
    Malar J; 2010 Feb; 9():46. PubMed ID: 20146804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
    Shi Q; Lynch MM; Romero M; Burns JM
    Infect Immun; 2007 Mar; 75(3):1349-58. PubMed ID: 17158895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
    Rotman HL; Daly TM; Long CA
    Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
    Rénia L; Ling IT; Marussig M; Miltgen F; Holder AA; Mazier D
    Infect Immun; 1997 Nov; 65(11):4419-23. PubMed ID: 9353014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia.
    Spencer Valero LM; Ogun SA; Fleck SL; Ling IT; Scott-Finnigan TJ; Blackman MJ; Holder AA
    Infect Immun; 1998 Aug; 66(8):3925-30. PubMed ID: 9673281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.
    Uthaipibull C; Aufiero B; Syed SE; Hansen B; Guevara Patiño JA; Angov E; Ling IT; Fegeding K; Morgan WD; Ockenhouse C; Birdsall B; Feeney J; Lyon JA; Holder AA
    J Mol Biol; 2001 Apr; 307(5):1381-94. PubMed ID: 11292349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.
    Stanisic DI; Martin LB; Liu XQ; Jackson D; Cooper J; Good MF
    Infect Immun; 2003 Oct; 71(10):5700-13. PubMed ID: 14500491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
    Adame-Gallegos JR; Shi J; McIntosh RS; Pleass RJ
    Exp Parasitol; 2012 Apr; 130(4):384-93. PubMed ID: 22343045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against malaria is conferred by passive transferring rabbit F(ab)(2)' antibody fragments, induced by Plasmodium falciparum MSP-1 site-directed designed pseudopeptide-BSA conjugates assessed in a rodent model.
    Lozano JM; Lesmes LP; Gallego GM; Patarroyo ME
    Mol Immunol; 2011 Jan; 48(4):657-69. PubMed ID: 21131051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM; Majarian WR; Young JF; Daly TM; Long CA
    J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii.
    Kedzierski L; Black CG; Coppel RL
    Mol Biochem Parasitol; 2000 Jan; 105(1):137-47. PubMed ID: 10613706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multigene family that interacts with the amino terminus of plasmodium MSP-1 identified using the yeast two-hybrid system.
    Mello K; Daly TM; Morrisey J; Vaidya AB; Long CA; Bergman LW
    Eukaryot Cell; 2002 Dec; 1(6):915-25. PubMed ID: 12477792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
    Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
    Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
    O'Donnell RA; Saul A; Cowman AF; Crabb BS
    Nat Med; 2000 Jan; 6(1):91-5. PubMed ID: 10613831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccine strains.
    Somner EA; Ogun SA; Sinha KA; Spencer Valero LM; Lee JJ; Harrison JA; Holder AA; Hormaeche CE; Khan ACM
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():221-229. PubMed ID: 10206702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection.
    Narum DL; Nguyen V; Zhang Y; Glen J; Shimp RL; Lambert L; Ling IT; Reiter K; Ogun SA; Long C; Holder AA; Herrera R
    Infect Immun; 2008 Nov; 76(11):4876-82. PubMed ID: 18710865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.
    Vukovic P; Hogarth PM; Barnes N; Kaslow DC; Good MF
    Infect Immun; 2000 May; 68(5):3019-22. PubMed ID: 10769007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Members of the merozoite surface protein 7 family with similar expression patterns differ in ability to protect against Plasmodium yoelii malaria.
    Mello K; Daly TM; Long CA; Burns JM; Bergman LW
    Infect Immun; 2004 Feb; 72(2):1010-8. PubMed ID: 14742548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.